Cara Lombardo
Wall Street Journal
Madison, WI, United States
Contact Cara
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Cara:
Top Morgan Stanley M&A Banker to Join Law Firm Paul Weiss
Veteran deal maker Rob Kindler has been at Morgan Stanley for 17 years. → Read More
Activist investor Starboard has nearly 5% stake in Splunk, seeks to boost stock
Activist investor Starboard Value LP has a sizable stake in Splunk Inc. and plans to push the software maker to take action to boost its stock price,... → Read More
Elon Musk, Twitter held unsuccessful talks about a price cut for acquisition
Representatives of Elon Musk and Twitter Inc. held unsuccessful talks about a possible price cut to his $44 billion deal to buy Twitter before he reversed... → Read More
Icahn, other big-name investors clean up on Elon Musk's Twitter reversal
Elon Musk’s decision to end his war with Twitter Inc. isn’t just a big win for the social-media company, but also for some big-name investors like Carl Icahn. → Read More
Twitter shareholders set to approve Elon Musk's $44 billion takeover bid
Twitter Inc.’s shareholders are poised to approve the $44 billion takeover that Elon Musk is now trying to exit, according to people familiar with the... → Read More
Warren Buffett not expected to vie for control of Occidental Petroleum
Warren Buffett’s bid to boost his big stake in Occidental Petroleum Corp. even further isn’t expected to serve as a prelude to a full takeover of the... → Read More
CVS seeking to buy Signify Health as part of home-health expansion
Signify Health is exploring strategic alternatives including a sale, The Wall Street Journal reported this past week. Initial bids are due this coming week... → Read More
Juul Rival NJOY Hires Bankers for Possible Sale
The e-cigarette maker, which has permission from the FDA to sell its tobacco-flavored products, also is simultaneously exploring a new fundraising round, according to people familiar with the matter. → Read More
Twitter Says Elon Musk’s Opposition to Expedited Trial Is a Tactical Delay
The social-media company said that the public dispute harms Twitter every day that Elon Musk is in breach of the merger agreement. → Read More
Merck Deal for Seagen Seen as Unlikely by Earnings Release
The deal talks are still on track but coming data and arbitration slowed the timeline, people familiar with the matter say. → Read More
Twitter files lawsuit against Elon Musk to force him to honour $44bn deal
Twitter said it has 'bent over backwards' to provide Musk with the information he has requested and is suing Musk to enforce consummation of the merger → Read More
Twitter Didn’t Seek a Sale. Now Elon Musk Doesn’t Want to Buy. Cue Strange Legal Drama.
In trying to terminate his $44 billion takeover deal, Tesla boss sets stage for what could become one of the oddest courtroom battles in corporate-takeover history. → Read More
Elon Musk Seeks to Abandon $44 Billion Twitter Deal
The tech entrepreneur is seeking to terminate his deal to buy the social-media company, saying it hasn’t provided data he needs to assess the prevalence of fake accounts, according to a regulatory filing. → Read More
Merck in talks to buy cancer biotech Seagen for about $40 billion
Merck & Co. is in advanced talks to acquire Seagen Inc. and is aiming to finalize a purchase of the cancer biotech in the next few weeks, according to people... → Read More
Merck Is in Advanced Talks to Buy Seagen for Roughly $40 Billion or More
A deal, potentially worth $40 billion or more, would help Merck broaden its lineup of cancer drugs, currently led by Keytruda. → Read More
Aerojet Rocketdyne CEO Poised to Win Proxy Fight Against Executive Chairman
Shareholders appear set to elect the eight-person board slate put forth by CEO Eileen Drake based on the votes that have come in ahead of the shareholder meeting Thursday. → Read More
Merck Pushes Forward With Potential Deal for Seagen
The talks have picked up pace and the two companies are scheduled to meet this week. → Read More
Zendesk Close to Striking Buyout Deal
A deal for the software company, with a market value of roughly $7 billion, would come after prior sale attempt fell apart. → Read More
Merck Explores Purchase of Biotech Seagen
Pulling off a deal for the cancer-focused biotech could be tricky given the risk of a regulatory challenge, and it is possible the companies could strike a marketing agreement instead. → Read More
Elon Musk Expected to Reiterate Desire to Own Twitter in Meeting Thursday
The billionaire also is likely to clarify remarks on remote work and strategy at a virtual meeting with the social-media platform’s employees on Thursday. → Read More